What is Spruce Biosciences, Inc. Common Stock?
is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for patients with Sanfilippo Syndrome Type B. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 124.47M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.